المؤلفون: Xavier Calvet, Javier P. Gisbert, Rafel Azagra, Jordi Sánchez-Delgado, Emili Gené

المصدر: Value in Health. 12(5):759-762

مصطلحات موضوعية: medicine.medical_specialty, Cost effectiveness, medicine.drug_class, Cost-Benefit Analysis, Proton-pump inhibitor, Peptic Ulcer Hemorrhage, Gastroenterology, Drug Costs, Helicobacter Infections, prevention, Internal medicine, bleeding peptic ulcer, Secondary Prevention, medicine, Humans, In patient, cost-effectiveness, treatment, Helicobacter pylori, biology, business.industry, Health Policy, Decision Trees, Public Health, Environmental and Occupational Health, Proton Pump Inhibitors, Health Care Costs, Cost-effectiveness analysis, biology.organism_classification, Clinical trial, Peptic ulcer bleeding, business

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::34b55a2444a12f983a254aa3b815cb54